The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Metagenomi, Inc. ("Metagenomi" or the ...

U.P. Oncolytics, a company in Rosalind Franklin University's Helix 51 biomedical incubator, has earned an NIH fast-track grant for the development of a novel treatment for a deadly form of brain ...

Actian, the data and analytics division of HCLSoftware, today announced it has been recognized as an Exemplary vendor in the ISG Buyers Guidestm for Data Quality and Data Integration. These ...

Modular Medical, Inc. ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult " ...

HYCU, Inc., a leader for modern data protection for on-prem, cloud services, and SaaS, and one of the fastest growing companies in the industry, today announced the appointment of Brian Babineau as ...

The Gross Law Firm issues the following notice to shareholders of Symbotic Inc. . Shareholders who purchased shares of SYM during ...

McDermott, through a consortium with Saipem and China Petroleum Engineering and Construction Corporation, has been awarded a front-end engineering design (FEED) contract for the Rovuma LNG Phase 1 ...

The GEO Group, Inc. ("GEO") will release its third quarter 2024 financial results on Thursday, November 7, 2024 before the market opens. GEO has scheduled a conference call and simultaneous webcast ...

GoldenPeaks Capital Holding Ltd (GPC), a leading independent power producer in Eastern Europe and China National Building Material Group Corporation (CNBM), a Fortune Global 500 enterprise, have ...

As dawn breaks over Hangji town in Yangzhou, Jiangsu Province, the first rays of sunlight spill onto the bustling streets, illuminating the rhythmic hum of toothbrush production lines. In a cozy ...

Le 24 septembre 2024, Huawei a annoncé avoir été reconnu par ses pairs comme un choix des clients 2024 Gartner® Peer ...

Shanghai Henlius Biotech, Inc. (2696.HK) et Organon ont annoncé que l'étude clinique comparative de phase 3 pour le ...